1. Home
  2. TACT vs RNXT Comparison

TACT vs RNXT Comparison

Compare TACT & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$3.58

Market Cap

37.2M

Sector

Technology

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.99

Market Cap

37.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TACT
RNXT
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
37.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
TACT
RNXT
Price
$3.58
$0.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$7.75
AVG Volume (30 Days)
57.9K
322.6K
Earning Date
03-12-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,258,000.00
$928,000.00
Revenue This Year
$21.67
$2,795.35
Revenue Next Year
$7.63
$272.69
P/E Ratio
N/A
N/A
Revenue Growth
8.27
N/A
52 Week Low
$3.12
$0.70
52 Week High
$5.70
$1.50

Technical Indicators

Market Signals
Indicator
TACT
RNXT
Relative Strength Index (RSI) 44.29 48.78
Support Level $3.50 $0.87
Resistance Level $3.73 $1.08
Average True Range (ATR) 0.25 0.07
MACD -0.00 -0.01
Stochastic Oscillator 22.50 47.43

Price Performance

Historical Comparison
TACT
RNXT

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: